ici 118551 has been researched along with evans blue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basbaum, AI; Benowitz, NL; Heller, PH; Helms, C; Levine, JD; Miao, FJ | 1 |
| Allen, MJ; Coleman, RA | 1 |
2 other study(ies) available for ici 118551 and evans blue
| Article | Year |
|---|---|
Chronically administered nicotine attenuates bradykinin-induced plasma extravasation and aggravates arthritis-induced joint injury in the rat.
Topics: Adrenal Medulla; Adrenergic beta-Antagonists; Animals; Arthritis, Experimental; Bradykinin; Dose-Response Relationship, Drug; Evans Blue; Heart Rate; Hexamethonium Compounds; In Vitro Techniques; Male; Nicotine; Propanolamines; Radiography; Rats; Rats, Sprague-Dawley | 1992 |
Beta 2-adrenoceptors mediate a reduction in endothelial permeability in vitro.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albumins; Albuterol; Analysis of Variance; Animals; Capillary Permeability; Catechols; Cattle; Cells, Cultured; Dioxoles; Dose-Response Relationship, Drug; Endothelium, Vascular; Evans Blue; Hydrogen Peroxide; Isoproterenol; Lipopolysaccharides; Nitroprusside; Propanolamines; Prostaglandin Endoperoxides, Synthetic; Pulmonary Artery; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Thrombin; Thromboxane A2; Vasoconstrictor Agents | 1995 |